.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
US Army
Baxter
Moodys
Harvard Business School
Cerilliant
Chinese Patent Office
Fuji
Boehringer Ingelheim
Dow

Generated: February 20, 2018

DrugPatentWatch Database Preview

Patents Expiring in March 2019

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Merck And Co IncEMENDfosaprepitant dimegluminePOWDER;INTRAVENOUS022023-002Nov 12, 2010APRXYesYes➤ Try a Free Trial➤ Try a Free TrialYY
Merck And Co IncEMENDfosaprepitant dimegluminePOWDER;INTRAVENOUS022023-001Jan 25, 2008DISCNYesNo➤ Try a Free Trial➤ Try a Free TrialYY
NovartisFORADILformoterol fumaratePOWDER;INHALATION020831-001Feb 16, 2001DISCNYesNo➤ Try a Free Trial➤ Try a Free Trial
AstrazenecaSYMBICORTbudesonide; formoterol fumarate dihydrateAEROSOL, METERED;INHALATION021929-002Jul 21, 2006RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
AstrazenecaSYMBICORTbudesonide; formoterol fumarate dihydrateAEROSOL, METERED;INHALATION021929-002Jul 21, 2006RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
AstellasMYCAMINEmicafungin sodiumINJECTABLE;IV (INFUSION)021506-002Mar 16, 2005RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYTREATMENT OF ESOPHAGEAL CANDIDIASIS AND PROPHYLAXIS OF CANDIDA INFECTIONS IN HSCT PATIENTS
Teva Pharms IntlSYNRIBOomacetaxine mepesuccinatePOWDER;SUBCUTANEOUS203585-001Oct 26, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYTREATMENT OF LEUKEMIA
AstellasMYCAMINEmicafungin sodiumINJECTABLE;IV (INFUSION)021506-002Mar 16, 2005RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYTREATMENT OF PATIENTS WITH CANDIDEMIA, ACUTE DISSEMINATED CANDIDIASIS, CANDIDA PERITONITIS AND ABSCESSES
Astrazeneca AbSYMLINpramlintide acetateINJECTABLE;SUBCUTANEOUS021332-001Mar 16, 2005DISCNNoNo➤ Try a Free Trial➤ Try a Free TrialYYTREATMENT OF DIABETES WITH AN AMYLIN AGONIST, INCLUDING WITH INSULIN
Astrazeneca AbSYMLINpramlintide acetateINJECTABLE;SUBCUTANEOUS021332-003Sep 25, 2007RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYTREATMENT OF DIABETES WITH AN AMYLIN AGONIST, INCLUDING WITH INSULIN
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Chubb
Moodys
Chinese Patent Office
Teva
Johnson and Johnson
Harvard Business School
US Department of Justice
Daiichi Sankyo
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot